These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27024912)

  • 1. [Serodiagnosis in the surveillance of the influenza virus circulation during the development of the pandemic caused by the A (H1N1)pdm09].
    Mukasheva E; Kolobukhina LV; Merkulova LV; Kisteneva LB; Zaplatnikov AL; Smolonogina TA; Desheva YA; Mikhaylova EV; Romanovskaya AV; Dubovitskaya NA; Burtseva EI
    Vopr Virusol; 2015; 60(6):19-24. PubMed ID: 27024912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longevity and determinants of protective humoral immunity after pandemic influenza infection.
    Sridhar S; Begom S; Hoschler K; Bermingham A; Adamson W; Carman W; Riley S; Lalvani A
    Am J Respir Crit Care Med; 2015 Feb; 191(3):325-32. PubMed ID: 25506631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of conservative and variable epitopes of the pandemic influenza virus A(H1N1)pdm09 hemagglutinin using monoclonal antibodies].
    Masalova OV; Chichev EV; Fediakina IT; Mukasheva EA; Klimova RR; Shchelkanov MIu; Burtseva EI; Ivanova VT; Kushch AA; L'vov DK
    Vopr Virusol; 2014; 59(3):34-40. PubMed ID: 25335417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
    Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
    PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine.
    Zuccotti G; Pogliani L; Pariani E; Amendola A; Zanetti A
    JAMA; 2010 Dec; 304(21):2360-1. PubMed ID: 21119083
    [No Abstract]   [Full Text] [Related]  

  • 8. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of an influenza pandemic in 13 countries from 5 continents monitored by protein microarray from neonatal screening bloodspots.
    de Bruin E; Loeber JG; Meijer A; Castillo GM; Cepeda ML; Torres-Sepúlveda MR; Borrajo GJ; Caggana M; Giguere Y; Meyer M; Fukushi M; Devi AR; Khneisser I; Vilarinho L; von Döbeln U; Torresani T; Mackenzie J; Zutt I; Schipper M; Elvers LH; Koopmans MP
    J Clin Virol; 2014 Sep; 61(1):74-80. PubMed ID: 25017954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009].
    Naĭkhin AN; Donina SA; Petukhova GD; Koren'kov EM; Doroshenko EM; Grigor'eva EP; Suvorova MA; Rudenko LG
    Vopr Virusol; 2013; 58(2):38-42. PubMed ID: 23785769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influenza viruses which preconditioned the epidemic rise in Russia in 2002-2003. A resumed circulation of influenza viruses similar to V/Victoria/2/87].
    Ivanova VT; Burtseva EI; Slepushkin AN; Oskerko TA; Zagorskaia IuV; Shevchenko ES; Mashkova SA; Feodoritova EL
    Vopr Virusol; 2004; 49(3):12-7. PubMed ID: 15188649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre-existing immunity is an essential factor for mild pandemic H1N1 2009].
    Wang DY; Shu YL
    Bing Du Xue Bao; 2011 May; 27(3):304-7. PubMed ID: 21774259
    [No Abstract]   [Full Text] [Related]  

  • 16. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.
    Makkoch J; Payungporn S; Prachayangprecha S; Tantilertcharoen R; Poovorawan Y
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):67-75. PubMed ID: 20527519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed 2009 pandemic influenza A virus subtype H1N1 circulation in West Africa, May 2009-April 2010.
    Nzussouo NT; Michalove J; Diop OM; Njouom R; Monteiro Mde L; Adje HK; Manoncourt S; Amankwa J; Koivogui L; Sow S; Elkory MB; Collard JM; Dalhatu I; Niang MN; Lafond K; Moniz F; Coulibaly D; Kronman KC; Oyofo BA; Ampofo W; Tamboura B; Bara AO; Jusot JF; Ekanem E; Sarr FD; Hwang I; Cornelius C; Coker B; Lindstrom S; Davis R; Dueger E; Moen A; Widdowson MA
    J Infect Dis; 2012 Dec; 206 Suppl 1():S101-7. PubMed ID: 23169954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans.
    Zhong W; Reed C; Blair PJ; Katz JM; Hancock K;
    J Infect Dis; 2014 Apr; 209(7):986-94. PubMed ID: 24325965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.